BioTelemetry (BioTelemetry) Long-Term Capital Lease Obligation : $0.2 Mil (As of Sep. 2020)

View and export this data going back to 2008. Start your Free Trial

What is BioTelemetry Long-Term Capital Lease Obligation?

BioTelemetry's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2020 was $0.2 Mil.

BioTelemetry's quarterly Long-Term Capital Lease Obligation declined from Mar. 2020 ($0.3 Mil) to Jun. 2020 ($0.2 Mil) and declined from Jun. 2020 ($0.2 Mil) to Sep. 2020 ($0.2 Mil).

BioTelemetry's annual Long-Term Capital Lease Obligation declined from Dec. 2017 ($1.5 Mil) to Dec. 2018 ($0.1 Mil) but then increased from Dec. 2018 ($0.1 Mil) to Dec. 2019 ($0.3 Mil).

BioTelemetry Long-Term Capital Lease Obligation Historical Data

The historical data trend for BioTelemetry's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioTelemetry Long-Term Capital Lease Obligation Chart

BioTelemetry Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.10

0.13

1.49

0.12

0.29

BioTelemetry Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.35	0.29	0.27	0.22	0.19

BioTelemetry (NAS:BEAT) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

BioTelemetry Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of BioTelemetry's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

BioTelemetry (BioTelemetry) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioTelemetry Inc (NAS:BEAT) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

1000 Cedar Hollow Road, Suite 102, Malvern, PA, USA, 19355

Website

https://www.gobio.com

BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. It operates under healthcare, technology, and research segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials and the Technology segment, focuses on the development, manufacturing, testing, and marketing of cardiovascular and blood glucose monitoring devices to medical companies, clinics and hospitals.

Executives

Kirk E Gorman	director	367 SOUTH GULPH ROAD, KING PRUSSIA PA 19406
Stephen Rietiker	director	C/O BIOTELEMETRY, INC., 1000 CEDAR HOLLOW RD. SUITE 102, MALVERN PA 19355
Tiffany Olson	director	C/O CASTLE BIOSCIENCES, INC., 505 S. FRIENDSWOOD DRIVE, SUITE 401, FRIENDSWOOD TX 77546
Joseph A. Frick	director	ONE COMMERCE SQUARE 2005 MARKET ST., SUITE 3300 19103 PR 19073
Laura N. Dietch	director	1000 CEDAR HOLLOW RD. SUITE 102 MALVERN PA 19355
Anthony James Conti	director	76 GOLFVIEW DRIVE, IVYLAND PA 18974
Rebecca W Rimel	director	345 PARK AVENUE, NEW YORK NY 10154
Robert J. Rubin	director	7901 SPRINGER ROAD, BETHESDA MD 20817
Hill Colin	director	196 BROADWAY CAMBRIDGE MA 02139
Andrei G Stoica	officer: SVP & CTO	1000 CEDAR HOLLOW ROAD, MALVERN PA 19355
Joseph H Capper	director, officer: President & CEO	BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
Manish Wadhwa	officer: SVP & CMO	1000 CEDAR HOLLOW ROAD MALVERN PA 19355
Fred Broadway	officer: President BioTel Heart	BIOTELEMETRY, INC. 1000 CEDAR HOLLOW ROAD, #102 MALVERN PA 19355
Daniel Wisniewski	officer: SVP, Technical Operations	BIOTELEMETRY, INC. 1000 CEDAR HOLLOW ROAD, #102 MALVERN PA 19355
Heather C Getz	officer: EVP, CFO & CAO	BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355